Efficacy of PRGF Supplementation After TMJ Arthrocentesis in Patients With TMJ Osteoarthritis
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Temporomandibular joint (TMJ) osteoarthritis (OA) affects articulating tissues secondary to
inflammation resulting in intracapsular pain. This prospective, double-blind randomized
clinical trial will evaluate the relative efficacy of TMJ arthrocentesis with a
supplementation of platelet-rich growth factors (PRGF) compared to TMJ arthrocentesis with a
steroid supplementation (a known effective therapy) for patients with TMJ OA.